Texas Dermatology Research Center | Plano, TX

Research site

Site insights

Top conditions

Top treatments


Data sourced from

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials
Locations recently updated

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS)

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (...

Hidradenitis Suppurativa
Drug: Upadacitinib
Drug: Placebo
Locations recently updated

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Atopic Dermatitis
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

Psoriasis is a long-term skin disease which causes red, itchy, scaly patches most commonly on the knees, elbows, scalp, and torso (chest, back, and a...

Moderate Plaque Psoriasis
Drug: Risankizumab
Drug: Deucravacitinib

The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneous using devices for injection at home.

Atopic Dermatitis
Combination Product: Rocatinlimab Prefilled Syringe

Trial sponsors

AbbVie logo
Amgen logo
Incyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems